Tislelizumab, un nuevo anticuerpo monoclonal anti-PD-1 para el cáncer urotelial: estudio de vida real
Article in Actas Urológicas Españolas (May 2024)
The most recent citing publications are shown below. View all 102 publications that cite this research output on Dimensions.
Article in Actas Urológicas Españolas (May 2024)
Article in Biomedicines (April 2024)
Article in Small (April 2024)